ArticleInternational journal of information technology : an official journal of Bharati Vidyapeeth's Institute of Computer Applications and Management2023
Logistic random forest boosting technique for Alzheimer's diagnosis.
Article in International journal of information technology : an official journal of Bharati Vidyapeeth's Institute of Computer Applications and Management, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 18 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer's disease (AD) is a common and well-known neurodegenerative condition that causes cognitive impairment. In the field of medicine, it is the "nervous system" disorder that has received the most attention. Despite this extensive research, there is no treatment or strategy to slow or stop its spread. Nevertheless, there are a variety of options (medication and non-medication alternatives) that may aid in the treatment of AD symptoms at their various phases, thereby enhancing the patient's quality of life. As AD advances over time, it is necessary to treat patients at their various stages appropriately. As a result, detecting and classifying AD phases prior to symptom treatment can be beneficial. Approximately twenty years ago, the rate of progress in the field of machine learning (ML) accelerated dramatically. Using ML methods, this study focuses on early AD identification. The "Alzheimer's Disease Neuroimaging Initiative" (ADNI) dataset was subjected to exhaustive testing for AD identification. The purpose was to classify the dataset into three groups: AD, "Cognitive Normal" (CN), and "Late Mild Cognitive Impairment" (LMCI). In this paper, we present the ensemble model Logistic Random Forest Boosting (LRFB), representing the ensemble of "Logistic Regression" (LR), "Random Forest" (RF), and "Gradient Boost" (GB). The proposed LRFB outperformed LR, RF, GB, "k-Nearest Neighbour" (k-NN), "Multi-Layer Perceptron" (MLP), "Support Vector Machine" (SVM), "AdaBoost" (AB), "Naïve Bayes" (NB), "XGBoost" (XGB), "Decision Tree" (DT), and other ensemble ML models with respect to the performance metrics "Accuracy" (Acc), "Recall" (Rec), "Precision" (Prec), and "F1-Score" (FS).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.